Vitamin E improves the uptake of unsaturated soya lecithin liposomes by human fibroblasts in vitro.
Liposomes may exert certain toxic effects on human cells depending on their composition and concentration when used as drug carriers. In this study, the behaviour of human fibroblasts in the presence of soya phosphatidylcholine (soya-PC) liposomes and the effect of the incorporation of vitamin E into the membrane of such liposomes, was investigated. Human fibroblasts were incubated for 72 h with low (50 microM) and high (200 microM) concentrations of large, unilamellar (LUV) soya-PC liposomes in the presence and absence of vitamin E (soya-PC:vitamin E; 10:0.5). The resulting cultures were studied by scanning and transmission electron microscopy, fluorescence microscopy and labelling with rhodamine B. The large unilamellar soya-PC liposomes obtained were of mean diameter 86.4 nm (soya-PC) and 78.3 nm (soya-PC: vitamin E). No significant changes in cell viability were observed between untreated fibroblasts and those incubated with 50 microM soya-PC liposomes. In contrast, a marked loss of cells was apparent at a concentration of 200 microM soya-PC liposomes which was reversible by the addition of vitamin E. Morphological changes including the production of microvilli or 'bubbling' of the cell membrane, were incurred by some of the fibroblasts on addition of soya-PC liposomes. The addition of vitamin E did not affect the changes produced at the lower liposome concentrations but was able to reduce the cytotoxic effects occurring at higher concentrations, possibly by inhibiting the formation of liposome aggregates. The use of PC-soya liposomes containing vitamin E at high concentrations is proposed as a means of delivering high doses of drugs.
Berrocal
M C
MC
Department of Nutrition and Bromatology, Faculty of Pharmacy, University of Alcalá de Henares, Madrid, Spain.
Buján
J
J
Jurado
F
F
Abeger
A
A
D002470:Cell Survival / Q000187:drug effects; D004337:Drug Carriers; D004339:Drug Compounding / Q000379:methods; D005347:Fibroblasts / Q000187:drug effects / Q000378:metabolism / Q000648:ultrastructure; D005456:Fluorescent Dyes; D006801:Humans; D066298:In Vitro Techniques; D008081:Liposomes; D008854:Microscopy, Electron; D008855:Microscopy, Electron, Scanning; D010316:Particle Size; D010713:Phosphatidylcholines / Q000008:administration & dosage* / Q000493:pharmacokinetics* / Q000633:toxicity; D012235:Rhodamines; D013025:Glycine max; D014810:Vitamin E / Q000008:administration & dosage*
D004337:Drug Carriers; D005456:Fluorescent Dyes; D008081:Liposomes; D010713:Phosphatidylcholines; D012235:Rhodamines; D014810:Vitamin E; C029773:rhodamine B